Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001210

Drug Information
NameNorgestimate    
SynonymsORF 10131; Norgestimatum [INN-Latin]; CHEBI:50815; (17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime; (3E)-17alpha-ethynyl-3-(hydroxyimino)-18a-homoestr-4-en-17beta-yl acetate; C017576; UNII-C291HFX4DY; (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime; NORGESTIMATE; CID6540478; 35189-28-7; NCGC00181353-01; D 138; D05209; d-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime; AC1O712U; ORF-10131; RWJ 10131; d-13-beta-Ethyl-17-alpha-ethynyl-17-beta-acetoxygon-4-en-3-one oxime; Dexnorgestrel acetime; Norgestimato [INN-Spanish]; Norgestimatum; 18,19-Dinor-17-pregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, oxime, (17alpha)- (+)-; AC-655; Norgestimate (USP/INN); DB00957; [(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate; norgestrel oxime acetate; LS-62080; Norgestimato; Ortho-Prefest; (+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester); Norgestimate [USAN:INN:BAN]; I14-9729; CHEMBL1200934; 18,19-Dinorpregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, 3-oxime, (17-alpha)-; RWJ-10131; ZINC03938695; 18,19-Dinor-17-pregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, oxime, (17alpha)-(+)-    
IndicationHormonal contraceptivesApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassContraceptive Agents    
CAS NumberCAS 35189-28-7
FormularC23H31NO3    
PubChem Compound IDCID 6540478.    
PubChem Substance IDSID 178495.    
ChEBI50815;    
TargetProgesterone receptorAgonist[2][3]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Pharmacological profile of progestins. Maturitas. 2008 Sep-Oct;61(1-2):151-7. To Reference
Ref 3A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch. Treat Endocrinol. 2006;5(6):359-65. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543